Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    B2C/B2B, Multiple product stages, Multiple funding stages, Pharma & Medical Biotechnology Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector (1)

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (4)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models (2)

    Product Stage (2)

    Employees 

    Location 

    Status 

    17 Startups 0 In the News 3 Recently Updated
    • Total Funding
      $791M
      Raised
      34
      Events
    • Private Funding
      $539M
      Raised
      27
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $252M
      Raised
      7
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    ImmPACT Bio logo

    ImmPACT Bio

    CAR-T Cell Therapies for Treating Cancer
    2017 B2B 51-200 B $137M
    biotechnology
    biopharmaceutical
    life-sciences
    genetic-engineering
    medical-technologies
    cancer-therapy
    hospitals
    healthcare-providers
    oncology
    cell-therapy
    cancer
    Sealantium Medical logo

    Sealantium Medical

    Tissue Sealants and Hemostatic Agents
    2011 B2B 1-10 B $11.57M
    first-aid
    medical-technologies
    surgery
    biotechnology
    biodegradable
    polymers
    hospitals
    critical-care
    tissue-regeneration
    Immunorizon logo

    Immunorizon

    Acquired
    T-and NK-cell Engagers for Cancer Therapy
    2017 B2B 1-10 Acquired Undisclosed
    cancer-therapy
    immunology
    oncology
    antibodies
    biotechnology
    Applied Immune Technologies logo

    Applied Immune Technologies

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    TCRL Antibodies for Therapeutic Applications
    2006 B2B 1-10 Acquired $4.4M
    viral-diseases
    cancer
    antibodies
    biotechnology
    biopharmaceutical
    therapeutics
    diagnostics
    autoimmune-diseases
    patients
    doctors
    Atox Bio logo

    Atox Bio

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunomodulators for Treatment of Infectious and Inflammatory Diseases
    2003 B2B 11-50 F $64.85M
    inflammatory-diseases
    infectious-disease
    ischemia
    immunology
    orphan-drug
    therapeutics
    critical-care
    pharmaceuticals
    immunotherapy
    patients
    biotechnology
    healthcare-providers
    BioSight logo

    BioSight

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutics for Oncology and Hematological Disorders
    1999 B2B 1-10 Acquired $62.5M
    chemotherapy
    cancer
    drug-discovery
    biopharmaceutical
    targeted-therapy
    pharmaceuticals
    cancer-therapy
    oncology
    hematology
    Inspiro Medical logo

    Inspiro Medical

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Dry Powder Inhaler
    2010 B2C 1-10 Acquired Undisclosed
    asthma
    medical-devices
    inhalation
    drug-delivery
    children
    pulmonary
    seniors
    respiratory
    adherence
    patients

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    17 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $791M
      Raised
      34
      Events
    • Private Funding
      $539M
      Raised
      27
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $252M
      Raised
      7
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    ImmPACT Bio logo
    Raised
    $137M
    ImmPACT Bio
    CAR-T Cell Therapies for Treating Cancer
    Founded:2017
    Business Model:B2B
    Employees:51-200
    Funding Stage:B
    Sealantium Medical logo
    Raised
    $11.57M
    Sealantium Medical
    Tissue Sealants and Hemostatic Agents
    Founded:2011
    Business Model:B2B
    Employees:1-10
    Funding Stage:B
    Immunorizon logo
    Raised
    Undisclosed
    Immunorizon
    Acquired
    T-and NK-cell Engagers for Cancer Therapy
    Founded:2017
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Applied Immune Technologies logo
    Raised
    $4.4M
    Applied Immune Technologies
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    TCRL Antibodies for Therapeutic Applications
    Founded:2006
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Atox Bio logo
    Raised
    $64.85M
    Atox Bio
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunomodulators for Treatment of Infectious and Inflammatory Diseases
    Founded:2003
    Business Model:B2B
    Employees:11-50
    Funding Stage:F
    BioSight logo
    Raised
    $62.5M
    BioSight
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutics for Oncology and Hematological Disorders
    Founded:1999
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Inspiro Medical logo
    Raised
    Undisclosed
    Inspiro Medical
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Dry Powder Inhaler
    Founded:2010
    Business Model:B2C
    Employees:1-10
    Funding Stage:Acquired
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,